Predicting pathological complete response in breast cancer early

Lancet Oncol. 2014 Dec;15(13):1415-1416. doi: 10.1016/S1470-2045(14)71020-4. Epub 2014 Oct 30.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / diagnostic imaging*
  • Carcinoma, Ductal, Breast / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Neoadjuvant Therapy*
  • Positron-Emission Tomography*
  • Receptor, ErbB-2 / metabolism*

Substances

  • Fluorodeoxyglucose F18
  • ERBB2 protein, human
  • Receptor, ErbB-2